Yin N, Yu H, Zhang X, & Lv X. (2020). Enhancement of Pancreatic Cancer Therapy Efficacy by Type-1 Matrix Metalloproteinase-Functionalized Nanoparticles for the Selective Delivery of Gemcitabine and Erlotinib. Dove Medical Press.
Chicago Style (17th ed.) CitationYin N, Yu H, Zhang X, and Lv X. Enhancement of Pancreatic Cancer Therapy Efficacy by Type-1 Matrix Metalloproteinase-Functionalized Nanoparticles for the Selective Delivery of Gemcitabine and Erlotinib. Dove Medical Press, 2020.
MLA (9th ed.) CitationYin N, et al. Enhancement of Pancreatic Cancer Therapy Efficacy by Type-1 Matrix Metalloproteinase-Functionalized Nanoparticles for the Selective Delivery of Gemcitabine and Erlotinib. Dove Medical Press, 2020.
Warning: These citations may not always be 100% accurate.